S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release

被引:89
作者
Hallström, S
Gasser, H
Neumayer, C
Fügl, A
Nanobashvili, J
Jakubowski, A
Huk, H
Schlag, G
Malinski, T
机构
[1] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA
[2] Univ Vienna, Dept Vasc Surg, Vienna, Austria
[3] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria
关键词
ischemia; reperfusion; nitric oxide; free radicals;
D O I
10.1161/01.CIR.0000018745.11739.9B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Peroxynitrite generated from nitric oxide (NO) and superoxide (O-2(-)) contributes to ischemia/reperfusion (I/R) injury. Feedback inhibition of endothelial NO synthase by NO may inhibit O-2(-) production generated also by endothelial NO synthase at diminished local L-arginine concentrations accompanying I/R. Methods and Results-During hindlimb I/R (2.5 hours/2 hours), in vivo NO was monitored continuously (porphyrinic sensor), and high-energy phosphates, reduced and oxidized glutathione (chromatography), and I/R injury were measured intermittently. Rabbits receiving human serum albumin (HSA) (controls) were compared with those receiving S-nitroso human serum albumin (S-NO-HSA) beginning 30 minutes before reperfusion for 1 hour or 30 minutes before ischemia for 3.5 hours (0.1 mumol . kg(-1) . h(-1)). The onset of ischemia led to a rapid increase of NO from its basal level (50 +/- 12 nmol/L) to 120+/-20 and 220+/-15 nmol/L in the control and S-NO-HSA-treated groups, respectively. In control animals, NO dropped below basal levels at the end of ischemia and to undetectable levels (<1 nmol/L) during reperfusion. In S-NO-HSA-treated animals, maximal NO levels never decreased below basal concentration and on reperfusion were 100 +/-15 nmol/L (S-NO-HSA preischemia group, 175 +/- 15 nmol/L). NO supplementation by S-NO-HSA led to partial and in the preischemia group to total preservation of high-energy phosphates and glutathione status in reperfused muscle (eg, preischemia groups: ATP, 30.23+/-5.02 μmol/g versus control, 15.75+/-4.33 μmol/g, P<0.0005; % oxidized glutathione, 4.49+/-1.87% versus control, 22.84+/-6.39%, P<0.0001). S-NO-HSA treatment in all groups led to protection from vasoconstriction and reduced edema formation after reperfusion (eg, preischemia groups: interfiber area, 12.94+/-1.36% versus control, 27.83+/-1.95%, P<0.00001). Conclusions-Long-lasting release Of NO by S-NO-HSA provides significant protection of skeletal muscle from I/R injury.
引用
收藏
页码:3032 / 3038
页数:7
相关论文
共 18 条
[11]   NITRIC-OXIDE RELEASE FROM A SINGLE CELL MEASURED INSITU BY A PORPHYRINIC-BASED MICROSENSOR [J].
MALINSKI, T ;
TAHA, Z .
NATURE, 1992, 358 (6388) :676-678
[12]  
Malinski T., 1996, METHODS NITRIC OXIDE, P319
[13]  
MARUBAYASHI S, 1984, BIOCHIM BIOPHYS ACTA, V797, P1
[14]   Determination of nitric oxide saturated (stock) solution by chronoamperometry on a porphyrine microelectrode [J].
Mesaros, S ;
Grunfeld, S ;
Mesarosova, A ;
Bustin, D ;
Malinski, T .
ANALYTICA CHIMICA ACTA, 1997, 339 (03) :265-270
[15]   NITRIC-OXIDE SYNTHASES - ROLES, TOLLS, AND CONTROLS [J].
NATHAN, C ;
XIE, QW .
CELL, 1994, 78 (06) :915-918
[16]  
POU S, 1992, J BIOL CHEM, V267, P24173
[17]  
STERNBERGH WC, 1993, SURGERY, V114, P960
[18]   DIRECT MEASUREMENT OF NITRIC-OXIDE IN HUMAN-BEINGS [J].
VALLANCE, P ;
PATTON, S ;
BHAGAT, K ;
MACALLISTER, R ;
RADOMSKI, M ;
MONCADA, S ;
MALINSKI, T .
LANCET, 1995, 346 (8968) :153-154